Clinical Trial Update: A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating recurrence-free survival in high-risk Type 1 autoimmune pancreatitis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Pancreatitis

Snippet

Sponsor: Ruijin Hospital | Conditions: Type 1 AIP | Phase 4 | Status: RECRUITING